Smith & Nephew plc (NYSE:SNN) Short Interest Update

Smith & Nephew plc (NYSE:SNN) was the recipient of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 2,140,000 shares, a decline of 23.3% from the December 31st total of 2,790,000 shares. Approximately 0.5% of the shares of the company are short sold. Based on an average daily trading volume, of 904,700 shares, the days-to-cover ratio is presently 2.4 days.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on SNN shares. Berenberg Bank lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Finally, StockNews.com lowered shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th.

Smith & Nephew Trading Down 1.1 %

Shares of Smith & Nephew stock traded down $0.28 during trading hours on Friday, reaching $25.38. The stock had a trading volume of 389,828 shares, compared to its average volume of 813,341. The stock’s 50 day moving average is $25.05 and its 200 day moving average is $27.64. Smith & Nephew has a twelve month low of $23.65 and a twelve month high of $31.72. The company has a current ratio of 2.51, a quick ratio of 1.11 and a debt-to-equity ratio of 0.63.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of SNN. Principal Securities Inc. grew its stake in Smith & Nephew by 87.6% during the 4th quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 691 shares in the last quarter. R Squared Ltd purchased a new stake in Smith & Nephew during the 4th quarter valued at about $41,000. GAMMA Investing LLC grew its stake in shares of Smith & Nephew by 160.0% in the 3rd quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock valued at $70,000 after buying an additional 1,389 shares during the period. Hara Capital LLC grew its stake in shares of Smith & Nephew by 391.4% in the 4th quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider’s stock valued at $60,000 after buying an additional 1,957 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its stake in shares of Smith & Nephew by 74.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,025 shares of the medical equipment provider’s stock valued at $94,000 after buying an additional 1,290 shares during the period. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.